Acyclovir Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - A Rare Case Report

Authors

DOI:

https://doi.org/10.37506/385gxd65

Keywords:

Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Acyclovir, Adverse Drug Reaction

Abstract

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis are serious, life-threatening conditions often triggered by drug reactions, characterized by widespread skin detachment and mucosal involvement. This case report describes a 29-year-old woman who developed Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis after receiving prophylactic acyclovir for suspected herpes. The patient initially presented with oral ulcers that rapidly progressed to widespread blisters, ulcers, and severe skin peeling. A thorough diagnostic evaluation, including skin biopsy and the Naranjo algorithm, identified acyclovir as the causative agent. The patient was managed in intensive care with intravenous methylprednisolone 500mg per day for 3 consecutive days as pulse therapy, antibiotics, and other supportive treatments. This case underscores the importance of early recognition, prompt discontinuation of the offending drug, and a multidisciplinary treatment approach. It also highlights the critical need for heightened awareness among healthcare professionals regarding the potential for severe adverse reactions with commonly used medications like acyclovir, to improve patient safety and outcomes.

References

Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens–Johnson syndrome and toxic epidermal necrolysis. Autoimmunity Reviews. 2008 Sep 1;7(8):598-605. https://doi.org/10.1016/j.autrev.2008.06.004

Lee HY, Martanto W, Thirumoorthy T. Epidemiology of Stevens–Johnson syndrome and toxic epidermal necrolysis in Southeast Asia. Dermatologica Sinica. 2013 Dec 1;31(4):217-20. https://doi.org/10.1016/j.dsi.2013.09.007

Shanbhag SS, Sangwan VS, Singh A, Donthineni PR, Basu S, Srinivasan B, Agarwal S, Iyer G. Clinical aspects of Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in India. Frontiers in Medicine. 2021 Aug 27;8:643955. http://dx.doi.org/10.1016/j.dsi.2013.09.007

Arndt KA. Adverse reactions to acyclovir: topical, oral, and intravenous. Journal of the American Academy of Dermatology. 1988 Jan 1;18(1):188-90. https://doi.org/10.1016/S0190-9622(88)70025-0

Hazin R, Ibrahimi OA, Hazin MI, Kimyai‐Asadi A. Stevens‐Johnson syndrome: pathogenesis, diagnosis, and management. Annals of medicine. 2008 Jan 1;40(2):129-38. https://doi.org/10.1080/07853890701753664

Frantz R, Huang S, Are A, Motaparthi K. Stevens–Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina. 2021 Aug 28;57(9):895. https://doi.org/10.3390/medicina57090895

Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H. ALDEN, an algorithm for assessment of drug causality in Stevens–Johnson syndrome and toxic epidermal necrolysis: comparison with case–control analysis. Clinical Pharmacology & Therapeutics. 2010 Jul;88(1):60-8. https://doi.org/10.1038/clpt.2009.252

Gupta LK, Martin AM, Agarwal N, D’Souza P, Das S, Kumar R, Pande S, Das NK, Kumaresan M, Kumar P, Garg A. Guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis: An Indian perspective. Indian journal of dermatology, venereology and leprology. 2016 Nov 1; 82: 603. https://doi.org/10.4103/0378-6323.191134

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics. 1981 Aug;30(2):239-45. https://doi.org/10.1038/clpt.1981.154

Coias JL, Abbas LF, Cardones AR. Management of Stevens-Johnson syndrome/toxic epidermal necrolysis: a review and update. Current Dermatology Reports. 2019 Dec;8:219-33. https://doi.org/10.1007/s13671-019-00275-0

Diana R, Rahayu T, Wirawan EP, Dhamayanti ME, Yuliarto D, Irawanto ME. Pathophysiology and management therapy of Steven-Johnson Syndrome (SJS) and Toxic Necrolysis Epidermal (TEN). Journal of General Procedural Dermatology & Venereology Indonesia. 2020 Dec 1;5(1):28. https://doi.org/10.19100/jdvi.v5i1.113

Sen SS, Sil A, Chakraborty U, Chandra A. Stevens-Johnson syndrome-toxic epidermal necrolysis: a fatal cutaneous adverse reaction to oral acyclovir. BMJ Case Reports. 2020;13(8). https://doi.org/10.1136%2Fbcr-2020-238555

Hirahara K, Kano Y, Sato Y, Horie C, Okazaki A, Ishida T, Aoyama Y, Shiohara T. Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers. Journal of the American Academy of Dermatology. 2013 Sep 1; 69(3): 496-8. https://doi.org/10.1016/j.jaad.2013.04.007

Shanbhag SS, Chodosh J, Fathy C, Goverman J, Mitchell C, Saeed HN. Multidisciplinary care in Stevens-Johnson syndrome. Therapeutic Advances in Chronic Disease. 2020 Apr;11:2040622319894469. https://doi.org/10.1177/2040622319894469

Downloads

Published

2024-12-03

How to Cite

Acyclovir Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - A Rare Case Report. (2024). Indian Journal of Forensic Medicine & Toxicology, 19(1), 18-23. https://doi.org/10.37506/385gxd65